Synergistic combination of Calcium Channel blockers Selective l-type for Gastrointestinal Tract and an Inert Silicon

摘要

The present Invention is Ada's relationship with the pharmaceutical industry in general and with industry faraceutica preparer medicaments for the Prevention and / or treatment of irritable bowel syndrome (IBS) and symptoms such as abdominal pain or discomfort associated with altered Tions of defecation and often abdominal distension, in particular.The Invention, compared with the same cvomposiciones purposes with the State of the Art, has the following Advantages: lower doses of each of the assets, the assets faster and less Side Effects.The composicione reflrja that the teachings of the present Invention comprises a synergistic combination of a blocker of l-type calcium channels with Selective Action on the smooth muscle Fiber of the intestinal tract and an antiflatulence Agent, as well as excipients framaceutica Aceptabeles mind.